Medical/Pharmaceuticals
Concord Medical Schedules 2020 Annual Meeting of Shareholders
BEIJING, Nov. 29, 2021 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specializing in cancer care, research and prevention by operating a network of medically advanced comprehensive cancer hospitals and standalone ...
2021-11-29 19:25
2718
Ascentage Pharma Appoints Mr. Yiqing Chen as Chief Financial Officer
SUZHOU, China, and ROCKVILLE, MD., Nov. 29, 2021 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced the appointment of Mr.Yiqing Chen as Chief Financ...
2021-11-29 19:01
2547
Help Therapeutics Completes Series C Financing of 25 Million Dollars
NANJING, China, Nov. 29, 2021 /PRNewswire/ -- Recently, the iPSC therapeutics leading global platform company -Help Therapeutics announced the completion of Series C financing of 25 millions of dollars. This round of financing was led by Ming Bioventures, followed by Share Capital, Beisen Medical...
2021-11-29 16:25
1833
Tigermed Recognized with Frost & Sullivan 2021 China Clinical CRO Competitive Strategy Leadership Award
HANGZHOU, China, Nov. 29, 2021 /PRNewswire/ -- Tigermed, a leading provider of innovative clinical research solutions for biopharmaceutical and medical device industry, announced that it has been awarded the Frost & Sullivan 2021 China Contract Research Organization (CRO) Competitive Strategy Lea...
2021-11-29 15:27
2530
Tang Prize Laureates Reflect on the Breakthroughs Made Possible by Cytokine Research
TAIPEI, Nov. 27, 2021 /PRNewswire/ -- Following the inspiring opening speech, "Future Perspective of Cancer Immunotherapy," delivered by Nobel Prize and Tang Prize laureate Prof.Tasuku Honjo at the 14th Asia Pacific Federation of Pharmacologist Conference (APFP) onNovember 26, the 2020 Tang Prize...
2021-11-27 16:00
5024
IASO Biotheraputics' CT120 Granted Orphan Drug Designation by the U.S. FDA
SAN JOSE, Calif., NANJING, China and SHANGHAI, Nov. 25, 2021 /PRNewswire/ -- IASO Biotherapeutics (IASO Bio), a clinical-stage biopharmaceutical company focusing on discovering, developing, and manufacturing innovative medicine announcedon Oct 26, 2021 that the Office of Orphan Products Developme...
2021-11-26 11:05
2143
Biotron Drug Effective Against COVID-19 In Animals
* BIT225 administered orally significantly reduced viral load in the lungs and blood of animals challenged with SARS-CoV-2. * BIT225 protected against severe disease, indicated by the significant prevention of body weight loss in animals treated with BIT225 compared to non-treated controls. ...
2021-11-25 19:00
2710
Kintor Pharma Receives IND Clearance by NMPA for KX-826's Pivotal Study to Treat Male Alopecia Patients
SUZHOU, China, Nov. 24, 2021 /PRNewswire/ -- Kintor Pharmaceutical Limited ("Kintor Pharma", HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecule and biological therapeutics, today announced that the IND application for the pivotal study (phase III stage) of p...
2021-11-24 23:14
2907
Neurophth Therapeutics Strengthens Leadership Team with Appointment of Su Zhang as Chief Financial Officer
SHANGHAI and SAN DIEGO, Nov. 24, 2021 /PRNewswire/ -- Neurophth Biotechnology Ltd., a fully-integrated genomic medicines company seeking to improve lives through the curative potential of gene therapies, today announced the recent appointment ofSu Zhang, M.B.A., as the Chief Financial Officer (CF...
2021-11-24 21:30
2324
GreenLight Biosciences and Samsung Biologics announce collaboration to build capacity for messenger RNA Vaccine Manufacturing
BOSTON and INCHEON, South Korea, Nov. 24, 2021 /PRNewswire/ -- GreenLight Biosciences (Nasdaq: ENVI), a biotechnology company dedicated to making ribonucleic acid (RNA) products affordable and accessible for human health and agriculture, and Environmental Impact Acquisition Corp, and Samsung Biol...
2021-11-24 20:00
2552
Next-generation Precision Medicine Company Allorion Therapeutics Completes Series A Financing Round
BOSTON, Nov. 24, 2021 /PRNewswire/ -- Allorion Therapeutics, a company focusing on next-generation precision medicine for oncology and autoimmune disease, today announced the completion of$40M Series A financing. This financing round is led by Qiming Venture Partners and participated by IDG Capit...
2021-11-24 16:11
1954
Amgen and Bushu Pharma Announce Expanded Supply Chain Partnership across Japan and Asia-Pacific Region
KAWAGOE, Japan, Nov. 24, 2021 /PRNewswire/ -- Bushu Pharmaceuticals Ltd. ("Bushu Pharma") has agreed on an expanded partnership with Amgen Inc. and Amgen K.K. to provide its "Gateway toAsia" service to four countries across the Asia-Pacific region as Amgen's contract manufacturing organization (C...
2021-11-24 15:00
2694
World's First｜Aopeng Medical Completes Clinical Trial of Robotic-Assisted Peripheral artery Intervention of iliac artery in human
SHANGHAI, Nov. 23, 2021 /PRNewswire/ -- On November , 2021, Aopeng Medical's ALLVAS™ Endovascular Intervention Surgical Robot, successfully completed the first-in-human clinical evaluation of robot-assisted peripheral artery intervention of iliac artery in the Department of Vascular Surgery at Sh...
2021-11-24 11:30
2071
Everest Medicines Announces Inclusion in the MSCI Global Small Cap Indexes - MSCI China Index
SHANGHAI, Nov. 23, 2021 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest" or the "Company"), a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients inAsia, today announced that th...
2021-11-24 08:00
2475
Gracell Biotechnologies Announces Senior Management Team Share Purchase Plan
SUZHOU, China and PALO ALTO, Calif., Nov. 23, 2021 /PRNewswire/ -- Gracell Biotechnologies Inc. (NASDAQ: GRCL) ("Gracell" or the "Company"), a global clinical-stage biopharmaceutical company dedicated to developing highly efficacious and affordable cell therapies for the treatment of cancer, toda...
2021-11-23 22:00
2955
Neurophth Raised Over $60 Million USD in Series-C Financing to Advance Gene Therapies
SAN DIEGO, Nov. 23, 2021 /PRNewswire/ -- Neurophth Therapeutics Ltd., ("Neurophth"), a fully integrated genomic medicines company dedicated on seeking to improve lives through the curative potential of gene therapies, today announced the closing of over$60 million USD in Series-C financing with a...
2021-11-23 21:30
2233
Qilian International Holding Group Limited Announces Inclusion of Gan Di Xin® and Qilian Shan® Oxytetracycline into List for Development of Leading Enterprises with Large Varieties and Brands of Pharmaceuticals of Gansu Province
JIUQUAN, China, Nov. 23, 2021 /PRNewswire/ -- Qilian International Holding Group Limited (Nasdaq: QLI) (the "Company"), aChina-based pharmaceutical and chemical products manufacturer, today announced that Gan Di Xin® and Qilian Shan® Oxytetracycline, products of the Company's subsidiary, Gansu Qi...
2021-11-23 20:00
2294
Bionomics Files Registration Statement for Proposed Initial Public Offering in the United States
ADELAIDE, Australia, Nov. 23, 2021 /PRNewswire/ -- Bionomics Limited (ASX:BNO, OTCQB:BNOEF) (Bionomics or Company), a clinical-stage biopharmaceutical company, today announced the public filing of a registration statement on Form F-1 with the U.S. Securities and Exchange Commission (the "SEC") in...
2021-11-23 19:37
3917
Simcere and Shanghai Institute of Materia Medica Enter a Collaboration to Jointly Develop Next-Gen COVID-19 Oral Antiviral Treatments
NANJING, China, Nov. 22, 2021 /PRNewswire/ -- On November 17, 2021, Simcere Pharmaceutical Group Limited (2096.HK) announced that the company has reached collaboration agreement with the Shanghai Institute ofMateria Medica (SIMM), Chinese Academy of Sciences (CAS), to develop novel antiviral drug...
2021-11-23 11:22
2651
Trajan Group acquires Axel Semrau GmbH
MELBOURNE, Australia, Nov. 22, 2021 /PRNewswire/ -- Global analytical science and device company Trajan Group Holdings Limited (ASX: TRJ) (Trajan or the Company) has completed the acquisition of Axel Semrau GmbH & Co. KG and Semrau Immobilien GmbH & Co. KG, the private business and properties of ...
2021-11-22 23:30
2472
Week's Top Stories
Most Reposted
Agoda Launches Free Global eSIMs for VIP Diamond Members
[Picked up by 322 media titles]
2026-02-10 14:00
DBS is First Bank in Asia Pacific to Pilot Visa Intelligent Commerce for Everyday Payments
[Picked up by 320 media titles]
2026-02-16 10:00
Ascentium Acquires Clara, Expanding into the Abu Dhabi Global Market (ADGM) and Strengthening its Middle East Presence
[Picked up by 310 media titles]
2026-02-12 14:00
Blackpanda Japan Announces Strategic Partnership with SoftBank to Strengthen Cyber Incident Response in Japan
[Picked up by 298 media titles]
2026-02-10 13:31Carro unveils quirky generative AI ad campaign highlighting its 'Surprisingly Short' AI-enabled car-selling process
[Picked up by 296 media titles]
2026-02-11 11:00
Most Read
Agoda Launches Free Global eSIMs for VIP Diamond Members
2026-02-10 14:00
6698
eufy Raises the Bar for Home Cleaning with Omni C28, Delivering One-Pass-Clean Performance with HydroJet™ Self-Clean Roller Mop
2026-02-14 10:00
6517
Datasea Reports Second Fiscal Quarter 2026 Results
2026-02-12 22:20
6486
NYSE Content Update: Forgent Power Solutions, Post IPO, to Ring Opening Bell
2026-02-12 21:56
5489
